Case 2:13-cv-00391-ES-JAD Document 384 Filed 08/23/17 Page 1 of 6 PageID: 7617
`
`Case 2:13-cv-00391-ES-JAD Document 384 Filed 08/23/17 Page 1 of 6 PageID: 7617
`
`UNITED STATES DISTRICT COURT
`DISTRICT OF NEW JERSEY
`
`JAZZ PHARMACEUTICALS, INC. and
`JAZZ PHARMACEUTICALS IRELAND
`
`Civil Action No. 13-391 (ES) (JAD)
`(consolidated)
`
`iled Electronicall
`
`y)
`
`(F
`
`LIMITED,
`
`V.
`
`Plaintiffs,
`
`
`
`
`
`
`AMNEAL PHARMACEUTICALS LLC,
`et al.,
`
`Defendants.
`
`
`
`
`STIPULATION AND ORDER REGARDING THE USE OF CERTAIN DISCOVERY
`MATERIALS FROM RELATED LITIGATION
`
`Whereas the above-captioned matter (the “Action”) has been noted as related to other
`
`actions currently or previously pending before this court, most notably Civil Action Nos. 10—cv-
`
`6108, 15-cv-1360, and 16-cv-4971 against Roxane Laboratories, Inc. (“Roxane Matters”);
`
`Whereas in the Roxane Matters, those parties engaged in discovery, including depositions
`
`of Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Limited (collectively, “Jazz”)
`
`witnesses pursuant to Fed. R. Civ. P. 30(b)(1) and Rule 30(b)(6);
`
`Whereas the parties to the Action recognize that there may be overlap of substantive
`
`issues between the Roxane Matters and the Action, such that depositions in the Roxane Matters
`
`may be relevant to the disputes in the Action and may shorten certain depositions or potentially
`
`eliminate the need for certain depositions;
`
`Whereas Jazz and Defendants Amneal Pharmaceuticals, LLC, Lupin Limited, Lupin
`
`Pharmaceuticals, Inc. and Lupin Inc., Watson Laboratories, Inc., and Par Pharmaceutical, Inc.
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 384 Filed 08/23/17 Page 1 of 6 PageID: 7617
`
`UNITED STATES DISTRICT COURT
`DISTRICT OF NEW JERSEY
`
`JAZZ PHARMACEUTICALS, INC. and
`JAZZ PHARMACEUTICALS IRELAND
`
`Civil Action No. 13-391 (ES) (JAD)
`(consolidated)
`
`iled Electronicall
`
`y)
`
`(F
`
`LIMITED,
`
`V.
`
`Plaintiffs,
`
`
`
`
`
`
`AMNEAL PHARMACEUTICALS LLC,
`et al.,
`
`Defendants.
`
`
`
`
`STIPULATION AND ORDER REGARDING THE USE OF CERTAIN DISCOVERY
`MATERIALS FROM RELATED LITIGATION
`
`Whereas the above-captioned matter (the “Action”) has been noted as related to other
`
`actions currently or previously pending before this court, most notably Civil Action Nos. 10—cv-
`
`6108, 15-cv-1360, and 16-cv-4971 against Roxane Laboratories, Inc. (“Roxane Matters”);
`
`Whereas in the Roxane Matters, those parties engaged in discovery, including depositions
`
`of Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Limited (collectively, “Jazz”)
`
`witnesses pursuant to Fed. R. Civ. P. 30(b)(1) and Rule 30(b)(6);
`
`Whereas the parties to the Action recognize that there may be overlap of substantive
`
`issues between the Roxane Matters and the Action, such that depositions in the Roxane Matters
`
`may be relevant to the disputes in the Action and may shorten certain depositions or potentially
`
`eliminate the need for certain depositions;
`
`Whereas Jazz and Defendants Amneal Pharmaceuticals, LLC, Lupin Limited, Lupin
`
`Pharmaceuticals, Inc. and Lupin Inc., Watson Laboratories, Inc., and Par Pharmaceutical, Inc.
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 384 Filed 08/23/17 Page 2 of 6 PageID: 7618
`
`Case 2:13-cv-00391-ES—JAD Document 384 Filed 08/23/17 Page 2 of 6 PageID: 7618
`
`(collectively, “Defendants”) (Jazz and Defendants referred to herein collectively as the “Parties”)
`
`to the Action wish to avoid unnecessary duplication of fact discovery in the Action;
`
`Whereas the patents currently asserted by Jazz in the Action are US. Patent Nos.
`
`6,780,889 B2, 7,262,219 B2, 7,668,730 82, 7,765,106 B2, 7,765,107 B2, 7,851,506 B2,
`
`7,895,059 B2, 8,263,650 B2, 8,324,275 B2, 8,457,988 B2, 8,589,182 82, 8,731,963 B2,
`
`8,772,306 B2, 8,859,619 B2, 8,952,062 B2, and 9,050,302 B2 (collectively,
`
`the “Asserted
`
`Patents”);
`
`NOW THEREFORE, the Parties, by and through their respective undersigned counsel in
`
`this Action, and subject to the approval of the Court, stipulate and agree as follows:
`
`1.
`
`Depositions of Jazz sponsored witnesses, taken pursuant to Rule 30(b)(1) in the
`
`Roxane Matters shall be relied upon in this Action as if the testimony were obtained in this
`
`Action, to the extent permitted pursuant to the Federal Rules of Civil Procedure, the Federal
`
`Rules of Evidence, and the Local Rules of Civil Practice and Procedure of the United States
`
`District Court for the District of New Jersey.
`
`Jazz will not object to the admissibility of the
`
`testimony as authentic, but reserves the right to object on any other basis under the Federal Rules
`
`of Evidence (“Fed. R. Evid.”).
`
`2.
`
`Depositions of Jazz employees taken pursuant to Rule 30(b)(6) in the Roxane
`
`Matters shall be relied upon in this Action as if the testimony were obtained in this Action, to the
`
`extent permitted pursuant to the Federal Rules of Civil Procedure, the Federal Rules of Evidence,
`
`and the Local Rules of Civil Practice and Procedure of the United States District Court for the
`
`District of New Jersey. Jazz will not object to the admissibility of the testimony as authentic, but
`
`reserves the right to object on any other basis under the Fed. R. Evid.
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 384 Filed 08/23/17 Page 3 of 6 PageID: 7619
`
`Case 2:13-cv-00391-ES—JAD Document 384 Filed 08/23/17 Page 3 of 6 PagelD: 7619
`
`3.
`
`The Parties agree to treat such depositions as Highly Confidential Information as
`
`defined in Section 1(b) of the Discovery Confidentiality Order governing this Action. See DE
`
`335.
`
`4.
`
`Defendants agree that they will not take depositions of Dayton Reardon, Harry
`
`Cook, Martha Hamilton, and Colette Goderstad in this Action pursuant to Rule 30(b)(1) and
`
`hereby withdraw their January 16, 2017 Notices of Deposition related to those individuals.
`
`Defendants further agree that they will not take the deposition of Mark Eller in this Action
`
`pursuant to Rule 30(b)(1) or Rule 45.
`
`5.
`
`Defendants agree to rely upon the Rule 30(b)(6) testimony of Jazz’s witnesses in
`
`the Roxane Matters and not to seek Rule 30(b)(6) testimony separately in this matter that is
`
`duplicative of testimony from the Roxane Matters, including testimony concerning conception
`
`and reduction to practice of the subject matter claimed in the patents—in-suit. Defendants will use
`
`best efforts to reasonably coordinate in advance of depositions to avoid duplicative questioning
`
`between themselves of a particular witness, and each party will use reasonable efforts to avoid
`
`duplicating examination of a particular witness on subject matter which was previously covered
`
`during the Roxane Matters. To that end, Defendants further agree to rely upon the Rule 30(b)(6)
`
`testimony of Jazz’s witnesses in the Roxane Matters concerning the actual sales of Xyrem
`
`through June 2016 and concerning the marketing of Xyrem through June 2016. Defendants
`
`agree that with respect to actual sales of Xyrem and the marketing of Xyrem, Defendants will
`
`only seek Rule 30(b)(6) testimony of Jazz concerning the actual sales of Xyrem and marketing of
`
`Xyrem from July 2016 to present.
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 384 Filed 08/23/17 Page 4 of 6 PageID: 7620
`
`Case 2:13-cv-00391—ES-JAD Document 384 Filed 08/23/17 Page 4 of 6 PageID: 7620
`
`6.
`
`Unless otherwise provided herein, nothing in this Stipulation prevents Defendants
`
`from noticing depositions of Jazz or other witnesses pursuant to Rule 30(b)(6) or Rule 30(b)(1),
`
`respectively.
`
`7.
`
`In the event Jazz asserts patents in this Action in addition to the Asserted Patents,
`
`Defendants reserve the right to notice depositions of Jazz or other witnesses in this Action
`
`pursuant to Rule 30(b)(6) or Rule 30(b)(1).
`
`AGREED AND STIPULATED TO:
`
`Dated: August 18, 2017
`
`Respectfully submitted,
`
`Respectfully submitted,
`
`By:
`
`s/Paul H. Kochanski
`Paul H. Kochanski
`
`LERNER, DAVID, LITTENBERG,
`KRUMHOLZ & MENTLIK, LLP
`600 South Avenue West
`
`Westfield, New Jersey 07090
`(908) 654-5000
`pkochanski@1dlkm.com
`
`W S
`
`teven A. Maddox
`
`Matthew C. Ruedy
`MADDox EDWARDS, PLLC
`1900 K Street NW — Suite 725
`
`Washington, DC. 20006
`(202) 830-0707
`
`Attorneys for Defendant
`Amneal Pharmaceuticals, LLC
`
`By:
`
`s/Charles M. Lizza
`Charles M. Lizza
`William C. Baton
`SAUL EWING LLP
`
`One Riverfront Plaza, Suite 1520
`Newark, New Jersey 07102-5426
`(973) 286-6700
`clizza@sau1.com
`
`OF COUNSEL:
`
`F. Dominic Cerrito
`
`Eric C. Stops
`Gabriel P. Brier
`
`QUINN EMANUEL URQUHART
`& SULLIVAN LLP
`51 Madison Avenue
`22nd Floor
`
`New York, New York 10010
`(212) 849-7000
`
`Richard G. Greco
`RICHARD G. GRECO PC
`
`90 State Street, Suite 700
`
`Albany, New York 12207
`(212) 203-7625
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 384 Filed 08/23/17 Page 5 of 6 PageID: 7621
`
`Case 2:13-cv-00391-ES-JAD Document 384 Filed 08/23/17 Page 5 of 6 PageID: 7621
`
`By:
`
`s/Melissa E. Flax
`James E. Cecchi
`Melissa E. Flax
`
`CARELLA, BYRNE, CECCHI,
`OLSTEIN, BRODY & AGNELLO, RC.
`5 Becker Farm Road
`
`Roseland, New Jersey 07068—1739
`(973) 994-1700
`JCecchi@carellabyme.com
`
`OF COUNSEL:
`
`William A. Rakoczy
`Paul J. Molino
`Deanne M. Mazzochi
`Jeff A. Marx
`RAKOCZY MOLINO MAZZOCHI
`SIWIK LLP
`
`6 West Hubbard Street, Suite 500
`Chicago, IL 60654
`(312) 527-2157
`jmarx@rmmslega1.com
`
`Attorneys for Defendants Lupin
`Limited, Lupin Pharmaceuticals,
`Inc. and Lupin Inc.
`
`Attorneys for Plaintififs
`Jazz Pharmaceuticals, Inc. and
`Jazz Pharmaceuticals Ireland
`Limited
`
`s/Liza M. Walsh
`Liza M. Walsh
`
`Tricia O’Reilly
`Katelyn O’Reilly
`WALSH PIZZI O’REILLY
`FALANGA LLP
`One Riverfront Plaza
`1037 Raymond Blvd., 6th Floor
`Newark, NJ 07105
`
`(973) 757-1100
`
`lwalsh@walsh.law
`
`OF COUNSEL:
`
`Gary E. Hood
`Mark T. Deming
`POLSINELLI PC
`
`150 North Riverside, Suite 3000
`Chicago, IL 60606
`(312) 819-1900
`ghood@polsinelli.com
`mdeming@polsinelli.com
`
`Attorneys for Defendant Watson
`Laboratories, Inc.
`
`st'Sean R. Kelly
`Sean R. Kelly
`Katherine A. Escanlar
`SAIBER LLC
`
`18 Columbia Turnpike
`Suite 200
`
`Florham Park, NJ 07932
`
`(973) 622-3333
`skelly@saiber.com
`kescanlar@saiber.com
`
`OF COUNSEL:
`
`Richard J. Berman
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 384 Filed 08/23/17 Page 6 of 6 PageID: 7622
`
`Case 2:13-cv-00391-ES—JAD Document 384 Filed 08/23/17 Page 6 of 6 PageID: 7622
`
`Janine A. Carlan
`Bradford C. Frese
`
`Gary A. Coad
`ARENT FOX LLP
`
`1717 K Street, NW
`
`Washington, DC 20006—5344
`(202) 857—6000
`richard.berman@arentfox.com
`janine.carlan@arentfox.com
`bradford.frese@arentfox.com
`gary.coad@arentfox.com
`
`Attorneys for Defendant Par
`Pharmaceutical, Inc.
`
`Week}
`
`Hon. Joseph A. Dickson
`UnitGd States Magistrate Judge
`
`O
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
